Plain-English translation of NCT07496034 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing whether , a traditional herbal medicine, can help people with episodic migraines (migraines that happen on some days but not others). The study will randomly assign participants to either receive the medication or a placebo (a pill with no active ingredient), and researchers will track whether the medication reduces how often migraines occur, eases migraine symptoms, and improves quality of life.
Many people with episodic migraines don't find relief with current treatments, or they experience side effects. This trial explores whether this traditional herbal approach could be a safe and effective option for managing migraines.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will be randomly assigned to receive either or a placebo, and you won't know which one you're getting. Throughout the study, you'll keep a detailed headache diary to track when migraines occur and how they affect you. Researchers will monitor your migraine frequency, symptoms, and overall well-being, as well as watch for any side effects to make sure the treatment is safe and tolerable.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
Taiwan